May 2017 Update
The May 2017 revision of the Cochrane Priority Reviews List includes new titles from the Cochrane Airways, Back and Neck, Heart, Movement Disorders, Schizophrenia and Tobacco Addictions Groups.
The following titles on the list are open to new authors:
- Immunomodulatory treatment for amyotrophic lateral sclerosis /motor neuron disease (ALS/MND) (Neuromuscular Disease)
- Supportive therapy for schizophrenia (Schizophrenia)
Cochrane-wide prioritisation remains an important project, with 170 priority reviews or updates published since the project began in January 2015.
Please be aware that all titles in the priority list have author teams in place, except for those mentioned above. If you are interested in one of these open titles please contact the relevant Cochrane Review Group before submitting a review proposal.
If you would like to contribute more generally to Cochrane’s prioritisation work, please contact the Editor in Chief, David Tovey (firstname.lastname@example.org).
Download the Cochrane Priority Review list for 2017 (May revision)
Ruth Foxlee, Information Specialist, Cochrane Editorial Unit
David Tovey, Editor in Chief, The Cochrane Library, and Deputy Chief Executive Officer